SoftWave TRT, LLC is a medical technology company that is developing advanced solutions specializing in shockwave therapy for better patient healing.
Founded in 2004 with Corporate Headquarters in Alpharetta, GA, SoftWave TRT is committed to the scientific advancement of tissue healing and regeneration and the development of the most effective innovations to improve the quality of lives globally. German-engineered with superior quality, it is used worldwide in the healthcare fields of orthopedics, traumatology, wound care, aesthetics, and urology.
SoftWave technology is trusted by the top major medical research centers in the U.S. and worldwide, with over 300 published studies of the technology supporting its effectiveness. It has a strong international presence with its German manufacturing partner and is internationally recognized by the International Society for Medical Shockwave Technology (ISMST).
SoftWave TRT, LLC was co-founded in 2004 by CEO John Warlick and business partner Mark Gronowski. The two men combined their years of experience in lithotripsy, a medical procedure that uses shock waves to dissolve kidney stones, and the predecessor technology to what we use today for extracorporeal shockwave therapy (ESWT), to form a new company–SoftWave TRT.
SoftWave’s purpose was designated to extend the medical use of shockwaves from lithotripsy and urology to nerve and tissue regeneration, musculoskeletal pain and injuries, cosmetics and likely many more indications that have yet to be discovered.
SoftWave is sometimes known as stemwave therapy. SoftWave TRT is the first and only supplier of unfocused shockwaves (Li-ESWT_ in North America and continues to research and develop new uses for unfocused shockwave therapy today.
SoftWave TRT is an innovator with a long list of patents. Click here to access the patent list.
From chronic non-healing soft tissue wounds to chronic tendinopathies to myofascial syndrome, this technology is changing lives one softwave at a time. The SoftWave team is continually researching, testing, and educating so we can hit our goal of having SoftWave be available to anyone that needs to prevent or heal an injury — because no one should have to settle for living in pain or with a chronic injury. — John Warlick, co-founder and CEO